Ocular Therapeutix, Inc. (OCUL) on GreekSoup https://greeksoup.ai/stocks/us/ocul/ Every dated entry in the public record on Ocular Therapeutix, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 30 Oct 2026 00:00:00 +0000 Ocular Therapeutix, Inc. filed 8-K: officer or director changehttps://greeksoup.ai/stocks/us/ocul/filings/us:OCUL:filing:2026-10-16:ee62f7cefdFri, 16 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc.: short interest 28,760,351 shares at the 15 October 2026 settlement, 8.10 days to coverhttps://greeksoup.ai/stocks/us/ocul/short-interest/us:OCUL:short-interest:2026-10-15:55b830fb51Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc.: Anderman Todd (Chief Legal Officer) sold 11,984 shares (under a trading plan set in advance) at $7.29 on 8 October 2026, $87,363https://greeksoup.ai/stocks/us/ocul/insiders/us:OCUL:insider:2026-10-13:0d8debc8b4Tue, 13 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc.: Form 144, TODD ANDERMAN plans to sell 11,984 shares worth $87,315 around 8 October 2026https://greeksoup.ai/stocks/us/ocul/planned-sales/us:OCUL:planned-sale:2026-10-08:dd5538a5dcThu, 08 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc.: Kaiser Peter (Chief Development Officer) sold 9,990 shares (under a trading plan set in advance) at $7.05 on 2 October 2026, $70,430https://greeksoup.ai/stocks/us/ocul/insiders/us:OCUL:insider:2026-10-06:f910198c4eTue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc.: Heier Jeffrey S. (Chief Scientific Officer) sold 10,869 shares (under a trading plan set in advance) at $7.05 on 2 October 2026, $76,626https://greeksoup.ai/stocks/us/ocul/insiders/us:OCUL:insider:2026-10-06:4db5c1ce0fTue, 06 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc.: Form 144, PETER KAZUO KAISER plans to sell 9,990 shares worth $70,459 around 2 October 2026https://greeksoup.ai/stocks/us/ocul/planned-sales/us:OCUL:planned-sale:2026-10-02:50d6e9b45bFri, 02 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc.: Form 144, JEFFREY S. HEIER plans to sell 10,869 shares worth $76,639 around 2 October 2026https://greeksoup.ai/stocks/us/ocul/planned-sales/us:OCUL:planned-sale:2026-10-02:9f47a441c8Fri, 02 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc.: short interest 29,412,673 shares at the 30 September 2026 settlement, 7.25 days to coverhttps://greeksoup.ai/stocks/us/ocul/short-interest/us:OCUL:short-interest:2026-09-30:bb05f2324dWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc.: short interest 29,933,140 shares at the 15 September 2026 settlement, 14.19 days to coverhttps://greeksoup.ai/stocks/us/ocul/short-interest/us:OCUL:short-interest:2026-09-15:e2ac950319Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc.: Notman Donald (Chief Operating Officer) sold 1,099 shares at $10.24 on 31 August 2026, $11,254https://greeksoup.ai/stocks/us/ocul/insiders/us:OCUL:insider:2026-09-02:e8edc151a2Wed, 02 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc.: Form 144, DONALD D NOTMAN JR. plans to sell 1,099 shares worth $11,252 around 31 August 2026https://greeksoup.ai/stocks/us/ocul/planned-sales/us:OCUL:planned-sale:2026-08-31:8ae818b4ceMon, 31 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc.: short interest 28,055,522 shares at the 31 August 2026 settlement, 8.96 days to coverhttps://greeksoup.ai/stocks/us/ocul/short-interest/us:OCUL:short-interest:2026-08-31:39ab53f52aMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc.: Kaiser Peter (Chief Development Officer) sold 3,035 shares (under a trading plan set in advance) at $10.77 on 24 August 2026, $32,687https://greeksoup.ai/stocks/us/ocul/insiders/us:OCUL:insider:2026-08-26:896620fbdbWed, 26 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc.: Nayak Sanjay (Chief Strategy Officer) sold 1,897 shares (under a trading plan set in advance) at $10.78 on 24 August 2026, $20,450https://greeksoup.ai/stocks/us/ocul/insiders/us:OCUL:insider:2026-08-26:ff7f020255Wed, 26 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc.: Heier Jeffrey S. (Chief Scientific Officer) sold 3,296 shares (under a trading plan set in advance) at $10.78 on 24 August 2026, $35,531https://greeksoup.ai/stocks/us/ocul/insiders/us:OCUL:insider:2026-08-26:7a64dbd0a6Wed, 26 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc.: Dugel Pravin (See Remarks) sold 21,649 shares (under a trading plan set in advance) at $10.77 on 24 August 2026, $233,160https://greeksoup.ai/stocks/us/ocul/insiders/us:OCUL:insider:2026-08-26:e00c43eabcWed, 26 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc.: Form 144, SANJAY NAYAK plans to sell 1,897 shares worth $20,453 around 24 August 2026https://greeksoup.ai/stocks/us/ocul/planned-sales/us:OCUL:planned-sale:2026-08-24:95c807434dMon, 24 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc.: Form 144, PETER KAZUO KAISER plans to sell 3,035 shares worth $32,702 around 24 August 2026https://greeksoup.ai/stocks/us/ocul/planned-sales/us:OCUL:planned-sale:2026-08-24:444d4d0f3dMon, 24 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc.: Form 144, JEFFREY S. HEIER plans to sell 3,296 shares worth $35,532 around 24 August 2026https://greeksoup.ai/stocks/us/ocul/planned-sales/us:OCUL:planned-sale:2026-08-24:08707ed484Mon, 24 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc.: Form 144, PRAVIN DUGEL plans to sell 21,649 shares worth $233,186 around 24 August 2026https://greeksoup.ai/stocks/us/ocul/planned-sales/us:OCUL:planned-sale:2026-08-24:27814aab29Mon, 24 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc.: short interest 28,515,335 shares at the 14 August 2026 settlement, 12.68 days to coverhttps://greeksoup.ai/stocks/us/ocul/short-interest/us:OCUL:short-interest:2026-08-14:3e90960b87Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc. Q2 FY2026 results: revenue $13 million, net income -$79 millionhttps://greeksoup.ai/stocks/us/ocul/results/fy2026-q2/us:OCUL:result:2026-08-03:d9d1ff6528Mon, 03 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc. filed S-8: form s-8https://greeksoup.ai/stocks/us/ocul/filings/us:OCUL:filing:2026-08-03:0f25eaa9fcMon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/ocul/filings/us:OCUL:filing:2026-08-03:dab36dde06Mon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Ocular Therapeutix, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/ocul/filings/us:OCUL:filing:2026-08-03:f0985fa3c9Mon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>